CIK 0000009326
- Large accelerated filer
BALCHEM CORP
Sign in to watch- Ticker
- BCPC
- Exchange
- Nasdaq
- Industry
- Chemicals & Allied Products
- FY end
- Dec 31
- Incorporated
- MD
- Entity type
- Operating
- EIN
- 132578432
- Phone
- +1 845-326-5600
- Business address
- 5 PARAGON DRIVE, MONTVALE, NJ, 07645
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2011-11-30 | Backus William A. Chief Accounting Officer | Exercise or conversion | +100 | $11.87 | $1K | 7,806 |
| 2011-11-30 | Backus William A. Chief Accounting Officer | Sale | −100 | $41.50 | $4K | 7,706 |
| 2011-11-30 | WEDRAL ELAINE R Director | Exercise or conversion | +15,000 | $7.32 | $110K | 58,540 |
| 2011-11-30 | WEDRAL ELAINE R Director | Sale | −15,000 | $40.50 | $608K | 43,450 |
| 2011-11-29 | WEDRAL ELAINE R Director | Exercise or conversion | +4,950 | $7.32 | $36K | 49,990 |
| 2011-11-29 | WEDRAL ELAINE R Director | Sale | −4,950 | $39.50 | $196K | 45,040 |
| 2011-11-28 | WEDRAL ELAINE R Director | Exercise or conversion | +5,050 | $7.32 | $37K | 50,090 |
| 2011-11-28 | WEDRAL ELAINE R Director | Sale | −5,050 | $39.35 | $199K | 45,040 |
| 2011-09-01 | TELEVANTOS JOHN Y Director | Grant or award | +3,000 | $6.78 | $20K | 48,040 |
| 2011-09-01 | TELEVANTOS JOHN Y Director | Sale | −3,000 | $41.50 | $125K | 45,040 |
| 2011-05-18 | TELEVANTOS JOHN Y Director | Grant or award | +3,750 | $6.78 | $25K | 48,790 |
| 2011-05-18 | TELEVANTOS JOHN Y Director | Sale | −3,750 | $40.67 | $153K | 45,040 |
| 2011-05-09 | Richardson Paul H VP, R&D | Exercise or conversion | +14,400 | $13.61 | $196K | 42,588 |
| 2011-05-09 | Richardson Paul H VP, R&D | Sale | −14,400 | $39.98 | $576K | 28,188 |
| 2011-03-21 | Richardson Paul H VP, R&D | Exercise or conversion | +10,749 | $11.87 | $128K | 35,264 |
| 2011-03-21 | Richardson Paul H VP, R&D | Sale | −10,749 | $34.02 | $366K | 24,515 |
| 2011-03-21 | Richardson Paul H VP, R&D | Exercise or conversion | +400 | $11.87 | $5K | 24,915 |
| 2011-03-21 | Richardson Paul H VP, R&D | Exercise or conversion | +3,100 | $13.61 | $42K | 28,015 |
| 2011-03-07 | Richardson Paul H VP, Research & Development | Exercise or conversion | +1,553 | $11.87 | $18K | 26,068 |
| 2011-03-07 | Richardson Paul H VP, Research & Development | Sale | −1,553 | $35.58 | $55K | 24,515 |
Page 51 of 79 · 1,574 trades